In older patients with NSTE-ACS, clopidogrel safely reduced bleeding compared with ticagrelor at 1 year.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 32926825.
- Also identified by DOI 10.7326/ACPJ202009150-028.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gimbel M, Qaderdan K, Willemsen L, et al. <b>Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.</b> Lancet. 2020;395:1374-81. 32334703.
Medical subject headings
- Acute Coronary Syndrome